1-deoxynojirimycin has been researched along with Heart Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, W; Jiang, L; Li, XY; Liu, J; Lu, L; Shi, H; Wang, X; Yang, J; Yu, S; Zhai, M; Zhang, L; Zhu, H | 1 |
| Arbustini, E; Barriales-Villa, R; Camporeale, A; Elliott, PM; Hagege, A; Kuusisto, J; Linhart, A; Moon, JC; Namdar, M; Nordbeck, P; Olivotto, I; Pieroni, M; Pietilä-Effati, P; Vujkovac, AC | 1 |
| Adelman, MH; Monte, SV; Paladino, JA; Schentag, JJ | 1 |
1 review(s) available for 1-deoxynojirimycin and Heart Diseases
| Article | Year |
|---|---|
Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week.
Topics: 1-Deoxynojirimycin; Electrocardiography; Enzyme Replacement Therapy; Fabry Disease; Heart; Heart Diseases; Humans | 2021 |
2 other study(ies) available for 1-deoxynojirimycin and Heart Diseases
| Article | Year |
|---|---|
1-Deoxynojirimycin attenuates septic cardiomyopathy by regulating oxidative stress, apoptosis, and inflammation via the JAK2/STAT6 signaling pathway.
Topics: 1-Deoxynojirimycin; Animals; Antiviral Agents; Apoptosis; Cardiomyopathies; Cytokines; Heart Diseases; Hypoglycemic Agents; Inflammation; Janus Kinase 2; Janus Kinases; Lipopolysaccharides; Mice; Oxidative Stress; Reactive Oxygen Species; Sepsis; Signal Transduction | 2022 |
Glucose supply and insulin demand dynamics of antidiabetic agents.
Topics: 1-Deoxynojirimycin; Acarbose; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dietary Carbohydrates; Energy Intake; Follow-Up Studies; Gluconeogenesis; Glucose; Glycated Hemoglobin; Heart Diseases; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Intestinal Absorption; Liver; Metformin; Myocardial Infarction; Thiazolidinediones | 2010 |